8. 失敗例
We would like to propose a new
systematic review entitled
“Tolvaptan for ADPKD”.
→すでに進行中
”Interventions for preventing the
progression of autosomal dominant
polycystic kidney disease.”
8
13. 失敗例
13
Dear Hiraku,
Thank you for your interest in undertaking the review
"Interventions for patients with suspected arteriovenous
fistula or graft infection" with our group.
Unfortunately the title you have suggested is not a priority
review topic for our group. Due to limited resources here at
the editorial base we are no longer able to support non-
priority reviews.
14. ポイント 3
逆に幅を広げすぎない
"interventions for acute
cardenolide (cardiac glycoside)
poisoning”
→We can't accept a proposal where
'any treatment' is eligible for inclusion
- because it is extremely difficult to
identify every treatment that could be
given to poisoned patients.
14
16. 失敗例
16
We have also just checked our specialised
register and there are currently no RCTs
looking at apheresis. Would you be prepared
to use non-randomised evidence?
“Therapeutic apheresis
for focal segmental glomerulosclerosis in adults”
22. 参考資料
2015.06.18 第4回コクランレビュータイトル登録セミナー事前課題
COCHRANE PREGNANCY AND CHILDBIRTH GROUP Title
Registration Form
Cochrane Library http://www.cochranelibrary.com
PROSPERO International prospective register of systematic
reviews http://www.crd.york.ac.uk/prospero/default.asp
Cochrane identifies priority topics for review 2015-2016
http://www.cochrane.org/news/cochrane-identifies-priority-
topics-review
22